{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:43:15Z","timestamp":1782801795270,"version":"3.54.5"},"reference-count":136,"publisher":"Georg Thieme Verlag KG","issue":"05\/06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Reprod Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prevalence of obesity among females of reproductive age is increasing globally. Access to the complete range of appropriate contraceptive options is essential for upholding the reproductive rights of this population group. People with obesity can experience stigma and discrimination when seeking healthcare, and despite limited evidence for provider bias in the context of contraception, awareness for its potential at an individual provider and health systems level is essential. While use of some hormonal contraceptives may be restricted due to increased health risks in people with obesity, some methods provide noncontraceptive benefits including a reduced risk of endometrial cancer and a reduction in heavy menstrual bleeding which are more prevalent among individuals with obesity. In addition to examining systems-based approaches which facilitate the provision of inclusive contraceptive care, including long-acting reversible contraceptives which require procedural considerations, this article reviews current evidence on method-specific advantages and disadvantages for people with obesity to guide practice and policy.<\/jats:p>","DOI":"10.1055\/s-0042-1760214","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T23:39:55Z","timestamp":1675726795000},"page":"246-257","source":"Crossref","is-referenced-by-count":4,"title":["Best Practice Contraception Care for Women with Obesity: A Review of Current Evidence"],"prefix":"10.1055","volume":"40","author":[{"given":"Kathleen","family":"McNamee","sequence":"additional","affiliation":[{"name":"Sexual Health Victoria, Box Hill, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Edelman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine, Oregon Health and Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Hang Wun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranvir","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Stanford University School of Medicine, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Bateson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Health, Daffodil Centre, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"key":"ref1","volume-title":"World Health Statistics 2021: Monitoring Health for the SDGs, Sustainable Development Goals","year":"2021"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/AOG.0000000000004703","article-title":"Association of obesity with longer time to pregnancy","volume":"139","author":"T Burger","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/13625187.2015.1023893","article-title":"The relationship between unplanned pregnancy and maternal body mass index 2009-2012","volume":"20","author":"A McKeating","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.contraception.2018.11.005","article-title":"Barriers and outcomes associated with unfulfilled requests for permanent contraception following vaginal delivery","volume":"99","author":"R Flink-Bochacki","year":"2019","journal-title":"Contraception"},{"issue":"01","key":"ref7","first-page":"14","article-title":"Obesity stigma: prevalence and impact in healthcare","volume":"1","author":"S Flint","year":"2015","journal-title":"Br J Obes"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.ijo.0803105","article-title":"Barriers to routine gynecological cancer screening for White and African-American obese women","volume":"30","author":"N K Amy","year":"2006","journal-title":"Int J Obes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-3-319-42542-9_7","article-title":"Obesity and endometrial cancer","volume":"208","author":"E Shaw","year":"2016","journal-title":"Recent Results Cancer Res"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ajcn\/79.3.379","article-title":"Waist circumference and not body mass index explains obesity-related health risk","volume":"79","author":"I Janssen","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"e43275","DOI":"10.1371\/journal.pone.0043275","article-title":"Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk","volume":"7","author":"M Guasch-Ferr\u00e9","year":"2012","journal-title":"PLoS One"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ijo.2013.32","article-title":"Waist circumference-to-height ratio predicts adiposity better than body mass index in children and adolescents","volume":"37","author":"P Brambilla","year":"2013","journal-title":"Int J Obes"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1210\/jc.2009-1584","article-title":"The predictive value of different measures of obesity for incident cardiovascular events and mortality","volume":"95","author":"H J Schneider","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/healthcare9111518","article-title":"Lean yet unhealthy: Asian American adults had higher risks for metabolic syndrome than non-Hispanic White adults with the same body mass index: evidence from NHANES 2011-2016","volume":"9","author":"L Zhu","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/humrep\/dew266","article-title":"The prevalence of unplanned pregnancy ending in birth, associated factors, and health outcomes","volume":"31","author":"J Goossens","year":"2016","journal-title":"Hum Reprod"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1363\/psrh.12134","article-title":"Comparing prospective and retrospective reports of pregnancy intention in a longitudinal cohort of U.S. women","volume":"52","author":"L J Ralph","year":"2020","journal-title":"Perspect Sex Reprod Health"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2007.10.012","article-title":"The relationship between body mass index and unintended pregnancy: results from the 2002 National Survey of Family Growth","volume":"77","author":"B Kaneshiro","year":"2008","journal-title":"Contraception"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"c2573","DOI":"10.1136\/bmj.c2573","article-title":"Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviours","volume":"340","author":"N Bajos","year":"2010","journal-title":"BMJ"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/phn.12182","article-title":"Late recognition of unintended pregnancies","volume":"32","author":"A B Ayoola","year":"2015","journal-title":"Public Health Nurs"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.contraception.2007.10.010","article-title":"Predictors of delay in each step leading to an abortion","volume":"77","author":"D G Foster","year":"2008","journal-title":"Contraception"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.contraception.2012.02.006","article-title":"Complications of surgical termination of second-trimester pregnancy in obese versus nonobese women","volume":"86","author":"L A Murphy","year":"2012","journal-title":"Contraception"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AOG.0000000000001006","article-title":"Obesity as a risk factor for complications after second-trimester abortion by dilation and evacuation","volume":"126","author":"L Lederle","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/AOG.0000000000001692","article-title":"Safety of outpatient surgical abortion for obese patients in the first and second trimesters","volume":"128","author":"L S Benson","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"238.e1","DOI":"10.1016\/j.ajog.2017.10.018","article-title":"Risk of complication during surgical abortion in obese women","volume":"218","author":"K S Mark","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1515\/jpm-2019-0103","article-title":"Effect of maternal obesity on pregnancy outcomes in women delivering singleton babies: a historical cohort study","volume":"47","author":"I Melchor","year":"2019","journal-title":"J Perinat Med"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","article-title":"Obesity and female infertility: potential mediators of obesity's impact","volume":"107","author":"D E Broughton","year":"2017","journal-title":"Fertil Steril"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12884-022-04904-8","article-title":"Incidence and risk factors for early pregnancy loss in women with first pregnancy undergoing in vitro fertilization-embryo transfer","volume":"22","author":"M Wang","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12884-022-04482-9","article-title":"Pre-pregnancy lifestyle characteristics and risk of miscarriage: the Australian Longitudinal Study on Women's Health","volume":"22","author":"M C Magnus","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijgo.12706","article-title":"Effect of body mass index on the outcome of IVF cycles among patients with poor ovarian response","volume":"144","author":"A M Maged","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/oby.20461","article-title":"Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20132013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery","volume":"21","author":"J I Mechanick","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00508-021-01986-w","article-title":"Reproductive outcomes after bariatric surgery in women","volume":"134","author":"D D Micic","year":"2022","journal-title":"Wien Klin Wochenschr"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamasurg.2018.1162","article-title":"Changes in sexual functioning in women and men in the 5 years after bariatric surgery","volume":"154","author":"K J Steffen","year":"2019","journal-title":"JAMA Surg"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2021.02.012","article-title":"Counseling, contraception, and conception rates in patients undergoing bariatric surgery: a retrospective review","volume":"104","author":"O Thornton","year":"2021","journal-title":"Contraception"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.soard.2020.12.007","article-title":"Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery","volume":"17","author":"C Moreira de Brito","year":"2021","journal-title":"Surg Obes Relat Dis"},{"issue":"03","key":"ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"K M Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"issue":"S 03","key":"ref37","first-page":"S12","article-title":"Mode of action of orlistat","volume":"21","author":"R Guerciolini","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s002280050134","article-title":"Lack of interaction between orlistat and oral contraceptives","volume":"50","author":"D Hartmann","year":"1996","journal-title":"Eur J Clin Pharmacol"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/AOG.0000000000004697","article-title":"Effect of topiramate on serum etonogestrel concentrations among contraceptive implant users","volume":"139","author":"A Lazorwitz","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"12","key":"ref41","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1177\/0091270010389471","article-title":"Treatment with liraglutide\u2013a once-daily GLP-1 analog\u2013does not reduce the bioavailability of ethinyl estradiol\/levonorgestrel taken as an oral combination contraceptive drug","volume":"51","author":"L V Jacobsen","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(20)30059-3","article-title":"Eating disorders","volume":"395","author":"J Treasure","year":"2020","journal-title":"Lancet"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.contraception.2016.09.003","article-title":"Does body mass index or weight perception affect contraceptive use?","volume":"95","author":"K Bhuva","year":"2017","journal-title":"Contraception"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmjsrh-2019-200479","article-title":"Association between young women's physical and mental health and their method of contraception in a longitudinal, population-based study","volume":"47","author":"I J Rowlands","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"issue":"05","key":"ref46","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.contraception.2017.11.007","article-title":"Obesity and contraceptive use among women 20-44 years of age in the United States: results from the 2011-15 National Survey of Family Growth (NSFG)","volume":"97","author":"W D Mosher","year":"2018","journal-title":"Contraception"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.whi.2009.08.002","article-title":"Contraceptive use and contraception type in women by body mass index category","volume":"19","author":"A Schraudenbach","year":"2009","journal-title":"Womens Health Issues"},{"issue":"08","key":"ref48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1089\/jwh.2016.5930","article-title":"Healthcare provider attitudes regarding contraception for women with obesity","volume":"26","author":"T C Jatlaoui","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"issue":"06","key":"ref49","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1634\/theoncologist.2009-0285","article-title":"Obesity and cancer","volume":"15","author":"K Y Wolin","year":"2010","journal-title":"Oncologist"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-20-0446","article-title":"Obesity is associated with heavy menstruation that may be due to delayed endometrial repair","volume":"249","author":"J J Reavey","year":"2021","journal-title":"J Endocrinol"},{"issue":"09","key":"ref51","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"A E Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cen.13828","article-title":"Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews","volume":"89","author":"E W Gilbert","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/00369330221107099","article-title":"Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: an updated meta-analysis","volume":"67","author":"Z Li","year":"2022","journal-title":"Scott Med J"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"H J Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"R Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/01.AOG.0000435452.86108.59","article-title":"Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use","volume":"122","author":"D S Grunloh","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpag.2019.03.008","article-title":"Assessing weight status in adolescent and young adult users of the etonogestrel contraceptive implant","volume":"32","author":"M E Romano","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"01","key":"ref58","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight","author":"M F Gallo","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"08","key":"ref59","first-page":"CD008815","article-title":"Progestin-only contraceptives: effects on weight","volume":"2016","author":"L M Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref61","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/AOG.0b013e31820f387c","article-title":"Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate","volume":"117","author":"A E Bonny","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method","volume":"160","author":"A E Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AOG.0b013e3181af68b2","article-title":"Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users","volume":"114","author":"Y L Le","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jpag.2021.08.004","article-title":"Does obesity influence body mass index changes in nulliparous adolescent users of long-acting reversible contraceptives?","volume":"34","author":"N Scott","year":"2021","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4236\/ojpm.2012.24069","article-title":"The effects of obesity on venous thromboembolism: a review","volume":"2","author":"G Yang","year":"2012","journal-title":"Open J Prev Med"},{"issue":"09","key":"ref66","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.amjmed.2005.03.012","article-title":"Obesity as a risk factor in venous thromboembolism","volume":"118","author":"P D Stein","year":"2005","journal-title":"Am J Med"},{"issue":"05","key":"ref67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/jamaneurol.2016.0001","article-title":"Risk of cerebral venous thrombosis in obese women","volume":"73","author":"S M Zuurbier","year":"2016","journal-title":"JAMA Neurol"},{"issue":"06","key":"ref68","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5\u2009mg) and 17\u03b2-oestradiol (1.5\u2009mg) (PRO-E2 study): risk of venous and arterial thromboembolism","volume":"26","author":"S Reed","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15761\/FWH.1000178","article-title":"Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: results from the extended INAS-SCORE study","volume":"5","author":"J Dinger","year":"2020","journal-title":"Front Womens Health"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"h2422","DOI":"10.1136\/bmj.h2422","article-title":"Fresh evidence confirms links between newer contraceptive pills and higher risk of venous thromboembolism","volume":"350","author":"S S Jick","year":"2015","journal-title":"BMJ"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"\u00d8 Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review","volume":"94","author":"N K Tepper","year":"2016","journal-title":"Contraception"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/AOG.0000000000003135","article-title":"Venous thromboembolism among women initiating depot medroxyprogesterone acetate immediately postpartum","volume":"133","author":"N K Tepper","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref75","doi-asserted-by":"crossref","first-page":"855","DOI":"10.5114\/aoms.2014.46206","article-title":"The incidence of acute myocardial infarction in relation to overweight and obesity: a meta-analysis","volume":"10","author":"J Zhu","year":"2014","journal-title":"Arch Med Sci"},{"issue":"05","key":"ref76","doi-asserted-by":"crossref","first-page":"e418","DOI":"10.1161\/STROKEAHA.109.576967","article-title":"Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants","volume":"41","author":"P Strazzullo","year":"2010","journal-title":"Stroke"},{"issue":"08","key":"ref77","first-page":"CD011054","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke","volume":"2015","author":"R E Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.contraception.2016.05.014","article-title":"Combined hormonal contraceptive use among obese women and risk for cardiovascular events: a systematic review","volume":"94","author":"L G Horton","year":"2016","journal-title":"Contraception"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40834-016-0008-3","article-title":"The effect of obesity on intraoperative complication rates with hysteroscopic compared to laparoscopic sterilization: a retrospective cohort study","volume":"1","author":"R Shepherd","year":"2016","journal-title":"Contracept Reprod Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1097\/01.AOG.0000447263.92717.14","article-title":"Interval surgical sterilization and obesity","volume":"123","author":"R Shepherd","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref81","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2016.02.003","article-title":"The safety of subcutaneously administered depot medroxyprogesterone acetate (104\u2009mg\/0.65\u2009mL): a systematic review","volume":"94","author":"M V Dragoman","year":"2016","journal-title":"Contraception"},{"issue":"21","key":"ref82","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"B Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"ref83","volume-title":"(Etonogestrel) USA approved product information","author":"Implanon NXT","year":"2021"},{"key":"ref84","volume-title":"(Etonogestrel) Australia approved product information","author":"Implanon NXT","year":"2021"},{"key":"ref85","volume-title":"Nexaplon UK Product information","year":"2022"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1016\/S0010-7824(98)00120-6","article-title":"Pharmacokinetics of Implanon. An integrated analysis","volume":"58","author":"J Huber","year":"1998","journal-title":"Contraception"},{"issue":"06","key":"ref87","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.contraception.2011.03.015","article-title":"Etonorgestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports","volume":"84","author":"C Ciangura","year":"2011","journal-title":"Contraception"},{"issue":"03","key":"ref88","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/AOG.0000000000000690","article-title":"Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration","volume":"125","author":"C McNicholas","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref89","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.contraception.2015.11.005","article-title":"Relationship between etonogestrel level and BMI in women using the contraceptive implant for more than 1 year","volume":"93","author":"K M Morrell","year":"2016","journal-title":"Contraception"},{"issue":"08","key":"ref90","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"2016","author":"L M Lopez","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"H Xu","year":"2012","journal-title":"Obstet Gynecol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience","volume":"13","author":"O Graesslin","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0010-7824(01)00226-8","article-title":"Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants","volume":"64","author":"I Sivin","year":"2001","journal-title":"Contraception"},{"issue":"01","key":"ref96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1363\/psrh.12017","article-title":"Contraceptive failure in the United States: estimates from the 2006-2010 National Survey of Family Growth","volume":"49","author":"A Sundaram","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(82)90171-8","article-title":"Metabolism of injectable formulations of contraceptive steroids in obese and thin women","volume":"26","author":"K Fotherby","year":"1982","journal-title":"Contraception"},{"issue":"01","key":"ref98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2003.09.005","article-title":"Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval","volume":"69","author":"J Smit","year":"2004","journal-title":"Contraception"},{"issue":"02","key":"ref100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/AOG.0000000000003089","article-title":"Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review","volume":"133","author":"S Dianat","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref101","first-page":"57","article-title":"Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers","volume":"35","author":"T K\u00fc\u00e7\u00fck","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices","volume":"91","author":"K Heinemann","year":"2015","journal-title":"Contraception"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2018.02.006","article-title":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study","volume":"149","author":"M Jareid","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"05","key":"ref104","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1002\/ijc.29229","article-title":"Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium","volume":"136","author":"A S Felix","year":"2015","journal-title":"Int J Cancer"},{"issue":"09","key":"ref105","first-page":"CD012658","article-title":"Levonorgestrel-releasing intrauterine system for endometrial hyperplasia","volume":"9","author":"T Mittermeier","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref106","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low-risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"N Pal","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref107","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study","volume":"216","author":"L Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"ref108","first-page":"CD000154","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding","volume":"2","author":"A Lethaby","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref109","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2017-02052","article-title":"Treatment options for hirsutism: a systematic review and network meta-analysis","volume":"103","author":"P Barrionuevo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"ref110","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"A O Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2016.10.010","article-title":"Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review","volume":"95","author":"M V Dragoman","year":"2017","journal-title":"Contraception"},{"issue":"02","key":"ref112","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.contraception.2009.02.013","article-title":"The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database","volume":"80","author":"S S Jick","year":"2009","journal-title":"Contraception"},{"issue":"08","key":"ref113","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annepidem.2006.01.001","article-title":"Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina","volume":"16","author":"L R Brunner Huber","year":"2006","journal-title":"Ann Epidemiol"},{"issue":"04","key":"ref114","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.contraception.2011.03.024","article-title":"The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women","volume":"84","author":"G A Schramm","year":"2011","journal-title":"Contraception"},{"issue":"01","key":"ref115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2015.09.013","article-title":"Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive","volume":"93","author":"S T Nakajima","year":"2016","journal-title":"Contraception"},{"issue":"06","key":"ref116","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.contraception.2008.12.013","article-title":"Association between efficacy and body weight or body mass index for two low-dose oral contraceptives","volume":"79","author":"R T Burkman","year":"2009","journal-title":"Contraception"},{"issue":"03","key":"ref117","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2011.08.001","article-title":"Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive","volume":"85","author":"C L Westhoff","year":"2012","journal-title":"Contraception"},{"issue":"02","key":"ref118","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1783\/147118901101195092","article-title":"Oral contraceptive failures and body weight: findings in a large cohort study","volume":"27","author":"M Vessey","year":"2001","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"03","key":"ref119","doi-asserted-by":"crossref","first-page":"263.e1","DOI":"10.1016\/j.ajog.2009.03.017","article-title":"Oral contraceptive effectiveness according to body mass index, weight, age, and other factors","volume":"201","author":"J C Dinger","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"ref120","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth","volume":"166","author":"L R Brunner Huber","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"07","key":"ref121","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.annepidem.2004.10.009","article-title":"The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth","volume":"15","author":"L R Brunner","year":"2005","journal-title":"Ann Epidemiol"},{"issue":"02","key":"ref122","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.contraception.2009.04.011","article-title":"Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity","volume":"80","author":"A B Edelman","year":"2009","journal-title":"Contraception"},{"issue":"05","key":"ref123","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2015.07.016","article-title":"Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis","volume":"92","author":"M Yamazaki","year":"2015","journal-title":"Contraception"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"M Zieman","year":"2002","journal-title":"Fertil Steril"},{"issue":"03","key":"ref125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.contraception.2020.11.011","article-title":"Efficacy, safety, and tolerability of a levonorgestrel\/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results","volume":"103","author":"A L Nelson","year":"2021","journal-title":"Contraception"},{"key":"ref126","first-page":"56S","article-title":"Higher body weight does not affect Nuvaring's efficacy","volume":"105","author":"C Westhoff","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref127","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.contraception.2012.12.001","article-title":"Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women","volume":"87","author":"M Dragoman","year":"2013","journal-title":"Contraception"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2012.04.022","article-title":"Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women","volume":"207","author":"C L Westhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"08","key":"ref129","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1016\/S2214-109X(19)30265-7","article-title":"Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials","volume":"7","author":"D F Archer","year":"2019","journal-title":"Lancet Glob Health"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0010-7824(94)90113-9","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"M F McCann","year":"1994","journal-title":"Contraception"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"100020","DOI":"10.1016\/j.conx.2020.100020","article-title":"A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4\u2009mg using a 24\/4-day regimen","volume":"2","author":"T Kimble","year":"2020","journal-title":"Contracept X"},{"issue":"07","key":"ref133","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/humrep\/des140","article-title":"The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience","volume":"27","author":"K Cleland","year":"2012","journal-title":"Hum Reprod"},{"issue":"02","key":"ref134","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2014.11.001","article-title":"Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception","volume":"91","author":"N Kapp","year":"2015","journal-title":"Contraception"},{"issue":"05","key":"ref135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.contraception.2019.01.003","article-title":"Pharmacokinetics of the 1.5\u2009mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index","volume":"99","author":"M Natavio","year":"2019","journal-title":"Contraception"},{"issue":"05","key":"ref136","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.contraception.2017.01.004","article-title":"Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index","volume":"95","author":"P Praditpan","year":"2017","journal-title":"Contraception"},{"issue":"06","key":"ref137","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.contraception.2016.05.002","article-title":"Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review","volume":"94","author":"T C Jatlaoui","year":"2016","journal-title":"Contraception"},{"issue":"01","key":"ref139","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.contraception.2016.03.006","article-title":"Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing","volume":"94","author":"A B Edelman","year":"2016","journal-title":"Contraception"},{"issue":"06","key":"ref140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.contraception.2012.05.012","article-title":"Results from pooled Phase III studies of ulipristal acetate for emergency contraception","volume":"86","author":"C Moreau","year":"2012","journal-title":"Contraception"},{"issue":"04","key":"ref141","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel","volume":"84","author":"A Glasier","year":"2011","journal-title":"Contraception"},{"issue":"01","key":"ref142","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/AOG.0000000000004717","article-title":"Double dosing levonorgestrel-based emergency contraception for individuals with obesity: a randomized controlled trial","volume":"140","author":"A B Edelman","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref144","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2011.12.004","article-title":"Contraceptive choices of overweight and obese women in a publically funded hospital: possible clinical implications","volume":"86","author":"R Scott-Ram","year":"2012","journal-title":"Contraception"},{"issue":"06","key":"ref145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0032-1328873","article-title":"Contraceptive use and sexual behavior in obese women","volume":"30","author":"B Kaneshiro","year":"2012","journal-title":"Semin Reprod Med"},{"issue":"03","key":"ref146","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.contraception.2018.05.011","article-title":"Surgical sterilization among US men and women with employer-based insurance: a claims data analysis","volume":"98","author":"A I Khan","year":"2018","journal-title":"Contraception"},{"issue":"05","key":"ref147","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.contraception.2016.06.016","article-title":"Contraceptive practices among women: the second Australian study of health and relationships","volume":"94","author":"J Richters","year":"2016","journal-title":"Contraception"},{"issue":"06","key":"ref148","first-page":"997","article-title":"Complications of interval laparoscopic tubal sterilization: findings from the United States Collaborative Review of Sterilization","volume":"96","author":"D J Jamieson","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref149","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.contraception.2019.05.003","article-title":"Relationship between body mass index and operative time in women receiving immediate postpartum tubal ligation","volume":"100","author":"N A Deshpande","year":"2019","journal-title":"Contraception"}],"container-title":["Seminars in Reproductive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1760214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T23:43:07Z","timestamp":1675726987000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1760214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":136,"journal-issue":{"issue":"05\/06","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1760214","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1526-8004","1526-4564"],"issn-type":[{"value":"1526-8004","type":"print"},{"value":"1526-4564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}